Evidence map›Paper›PMID 23824281›Full record

ArticleNanoscale2013

Cytotoxicity and DNA cleavage with core-shell nanocomposites functionalized by a KH domain DNA binding peptide.

Remon Bazak, Jan Ressl, Sumita Raha, Caroline Doty, William Liu, Beau Wanzer, Seddik Abdel Salam, Samy Elwany, Tatjana Paunesku, Gayle E Woloschak

Abstract read
In one paragraph

Article in Nanoscale, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 17 citations in OpenAlex.

  1. Development of FeCancer nanotechnology · 2021
    Article
  2. IntracellularNano research · 2018
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Remon BazakDepartment of Otorhinolaryngology and Head & Neck Surgery, University of Alexandria Medical School, Azarita Medical Campus, Champollion Street, Khartoum Square, Alexandria, Egypt. dr_remon77@yahoo.com.
Jan Ressl
Sumita Raha
Caroline Doty
William Liu
Beau Wanzer
Seddik Abdel Salam
Samy Elwany
Tatjana Paunesku
Gayle E Woloschak
Northwestern University · USAlexandria University · EG

Funding

Theranostic Magnetic Nanostructures for the Molecular Imaging of CancerU54CA151880 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MRKSICH, MILAN · 2010 to 2014
$11.5M
Applications of TiO2-DNA nanocompositesR01EB002100 · NIBIB · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WOLOSCHAK, GAYLE E. · 2005 to 2013
$2.5M
NCI NIH HHS U54 CA151880NIBIB NIH HHS EB002100NIBIB NIH HHS R01 EB002100
6 · The paper itself

Abstract

A nanoconjugate was composed of metal oxide nanoparticles decorated with peptides and fluorescent dye and tested for DNA cleavage following UV light activation. The peptide design was based on a DNA binding domain, the so called KH domain of the hnRNPK protein. This "KH peptide" enabled cellular uptake of nanoconjugates and their entry into cell nuclei. The control nanoconjugate carried no peptide; it consisted only of the metal oxide nanoparticle prepared as Fe3O4@TiO2 nanocomposite and the fluorescent dye alizarin red S. These components of either construct are responsible for nanoconjugate activation by UV light and the resultant production of reactive oxygen species (ROS). Production of ROS at different subcellular locations causes damage to different components of cells: only nanoconjugates inside cell nuclei can be expected to cause DNA cleavage. Degradation of cellular DNA with KH peptide decorated nanoconjugates exceeded the DNA damage obtained from control, no-peptide nanoconjugate counterparts. Moreover, caspase activation and cell death were more extensive in the same cells.

Indexed as

ApoptosisCell Line, TumorDNADNA CleavageFerrosoferric OxideHeterogeneous-Nuclear Ribonucleoprotein KHumansMetal NanoparticlesMicroscopy, ConfocalNanocompositesPeptidesProtein BindingProtein Structure, TertiaryReactive Oxygen SpeciesRibonucleoproteinsTitaniumDNAFerrosoferric OxideHeterogeneous-Nuclear Ribonucleoprotein KHNRNPK protein, humanPeptidesReactive Oxygen SpeciesRibonucleoproteinsTitaniumtitanium dioxide

Identifiers

PMID23824281
PMCPMC3825787
OpenAlexW1999315675

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.